Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,123 | 583 | 97.3% |
| Education | $253.48 | 8 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,332 | 75 | $0 (2024) |
| Novo Nordisk Inc | $959.68 | 84 | $0 (2024) |
| PFIZER INC. | $734.76 | 52 | $0 (2024) |
| ABBVIE INC. | $712.39 | 48 | $0 (2024) |
| Astellas Pharma US Inc | $613.32 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $604.48 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $494.30 | 35 | $0 (2022) |
| Amgen Inc. | $474.21 | 31 | $0 (2024) |
| Lilly USA, LLC | $439.00 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $294.94 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $972.66 | 49 | AstraZeneca Pharmaceuticals LP ($184.40) |
| 2023 | $1,198 | 69 | AbbVie Inc. ($181.61) |
| 2022 | $1,357 | 75 | ABBVIE INC. ($236.59) |
| 2021 | $1,734 | 98 | Watermark Medical, Inc. ($201.42) |
| 2020 | $988.18 | 63 | PFIZER INC. ($168.74) |
| 2019 | $918.40 | 58 | AstraZeneca Pharmaceuticals LP ($182.00) |
| 2018 | $1,208 | 104 | Novo Nordisk Inc ($229.12) |
| 2017 | $999.68 | 75 | AstraZeneca Pharmaceuticals LP ($200.82) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Obesity | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Biological | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Biological | ||||||
| 09/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $35.65 | General |
| Category: Central Nervous System | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.14 | General |
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Bone Health | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Obesity | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,077 | 1,452 | $226,347 | $106,844 |
| 2022 | 15 | 1,110 | 1,586 | $215,991 | $111,474 |
| 2021 | 17 | 1,305 | 2,394 | $257,719 | $104,558 |
| 2020 | 14 | 1,182 | 1,436 | $181,875 | $57,497 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 503 | $103,240 | $39,310 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 211 | 211 | $28,575 | $25,740 | 90.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 177 | 180 | $46,455 | $19,551 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 170 | $24,330 | $9,185 | 37.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 27 | $9,450 | $5,639 | 59.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 207 | 207 | $4,140 | $3,495 | 84.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $1,980 | $1,888 | 95.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 31 | 31 | $4,185 | $1,256 | 30.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 44 | $2,816 | $392.76 | 13.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 26 | $520.00 | $247.52 | 47.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 30 | 41 | $656.00 | $139.81 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 406 | $75,570 | $33,253 | 44.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 207 | 215 | $51,420 | $23,944 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 180 | 180 | $24,185 | $22,749 | 94.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 221 | $28,855 | $12,778 | 44.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 24 | $8,400 | $4,997 | 59.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 189 | 189 | $3,760 | $3,287 | 87.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 32 | 120 | $7,200 | $3,110 | 43.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 18 | 18 | $2,970 | $2,779 | 93.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 32 | 76 | $5,700 | $1,940 | 34.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,815 | $908.60 | 50.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 13 | $1,160 | $640.77 | 55.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 16 | 16 | $1,920 | $455.09 | 23.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 28 | 29 | $1,856 | $263.47 | 14.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 23 | $460.00 | $213.37 | 46.4% |
About Dr. Robert Carlson, M.D
Dr. Robert Carlson, M.D is a Family Medicine healthcare provider based in Hastings, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396856910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Carlson, M.D has received a total of $9,376 in payments from pharmaceutical and medical device companies, with $972.66 received in 2024. These payments were reported across 591 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($9,123).
As a Medicare-enrolled provider, Carlson has provided services to 4,674 Medicare beneficiaries, totaling 6,868 services with total Medicare billing of $380,373. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hastings, MI
- Active Since 08/31/2006
- Last Updated 01/07/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396856910
Products in Payments
- FARXIGA (Drug) $757.63
- CHANTIX (Drug) $406.29
- Victoza (Drug) $406.28
- XARELTO (Drug) $402.94
- JARDIANCE (Drug) $312.00
- UBRELVY (Drug) $289.27
- NURTEC ODT (Drug) $245.10
- Vascepa (Drug) $239.24
- Kerendia (Drug) $231.32
- VRAYLAR (Drug) $223.92
- Ozempic (Drug) $220.76
- MYRBETRIQ (Drug) $213.51
- ARES HOME SLEEP TESTING DEVICE (Device) $201.42
- EVENITY (Biological) $195.89
- STIOLTO RESPIMAT (Drug) $180.79
- BREZTRI (Drug) $173.60
- TRELEGY ELLIPTA (Drug) $158.85
- SYMBICORT (Drug) $149.92
- Veozah (Drug) $142.38
- Prolia (Biological) $142.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hastings
Dr. Diane Ebaugh, M.d, M.D
Family Medicine — Payments: $13,128
Curtis Reimer, Md, MD
Family Medicine — Payments: $7,036
Dr. Matthew Dvorchak, M.d, M.D
Family Medicine — Payments: $7,031
David Schram, Md, MD
Family Medicine — Payments: $6,413
Diana Diemer, Fnp, FNP
Family Medicine — Payments: $5,508
Mackenzie Hemje, Md, MD
Family Medicine — Payments: $4,755